139155-55-8

Basic information

• Product Name: 1-bromo-3-isobutylbenzene
• Synonyms: 1-bromo-3-isobutylbenzene
• CAS NO: 139155-55-8
• Molecular Formula: C₁₀H₁₃Br
• Molecular Weight: 213.11422
• Mol File: 139155-55-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-bromo-3-isobutylbenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-3-isobutylbenzene(139155-55-8)
• EPA Substance Registry System: 1-bromo-3-isobutylbenzene(139155-55-8)

Safety Data

• Hazardous Substances Data: 139155-55-8(Hazardous Substances Data)

Usage

General Description

1-bromo-3-isobutylbenzene is a chemical compound with the molecular formula C10H13Br. It is a colorless liquid that is used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. This chemical is derived from benzene and features a bromine atom and an isobutyl group. It is important to handle 1-bromo-3-isobutylbenzene with caution as it is a flammable substance and can cause irritation to the eyes, skin, and respiratory system upon contact. Proper safety measures should be taken when handling and storing this chemical to prevent potential hazards.

Upstream product

• 64781-38-0 1-bromo-3-(2-methylprop-1-en-1-yl)benzene 
• 3132-99-8 m-bromobenzoic aldehyde 
• 131826-11-4 3-isobutylaniline 
• 591-18-4 1-Bromo-3-iodobenzene 
• 926-62-5 isobutylmagnesium bromide 

Downstream Products

• 139155-54-7 3-isobutylbenzaldehyde 
• 914644-70-5 3-isobutylbenzyl bromide 
• 914644-71-6 (2R,5S)-1-benzoyl-5-(3-isobutylbenzyl)-2-tert-butyl-3-methyltetrahydropyrimidin-4(1H)-one 
• 125604-09-3 3-(2-methylpropyl)-benzyl alcohol 
• 1244763-22-1 C₁₈H₂₁N₃ 
• 139155-56-9 bis(3-isobutylphenyl)methanol 
• 153624-42-1 3-isobutylphenylboronic acid 

Relevant articles and documents

SUBSTITUTED PARA-BIPHENYLOXYMETHYL DIHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF

The present invention relates to a series of substituted para-biphenyloxymethyl dihydro oxazolopyrimidinones of formula (I) as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of

β-AMINO ACID DERIVATIVES

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, R8 and R9 are as defined herein, as well as to compositions containing such a compound and the uses of such a compound. Compounds of formula (I) are especially useful in the treatment of pain.

Manufacture of optically active α-arylalkanoic acids and precursors thereof

This invention concerns a new process of preparing optically active α-arylalkanoic acids and their precursors. These α-arylalkanoic acids, esters, amides, nitriles, oxazolines and metal salts are stereoselectively prepared by forming the metal or metal halide of the corresponding acid, ester, amide, oxazoline, nitrile, or metal salt and treating the compound so prepared with an aryl halide in the presence of a chiral (optically active) transition metal catalyst of the formula (LL*)QZT wherein Q is a transition metal selected from palladium and nickel; Z and T are independently halogen; and LL* is a chiral tertiary diphosphine compound capable of acting as a bidentate ligand with Q to form a 5-membered ring, optionally in the presence of a dipolar aprotic solvent or mixtures thereof, for a time sufficient to form the corresponding optically active α-arylalkanoic acid, ester, amide, nitrile, oxazoline or metal salt, and optionally concomitantly or sequentially hydrolyzing any ester, amide, nitrile, oxazoline or metal salt formed to the corresponding optically active α-arylalkanoic acid. The process optionally further includes removal of halogen atom from the aromatic portion of the α-arylalkanoic acid. The process optionally includes subsequent formation of the pharmaceutically acceptable salts and esters of the optionally active α-arylalkanoic acid. This is a simple process for the preparation of the described optically active α-arylalkanoic acids. These compounds are useful as pharmaceutical (e.g., anti-inflammatory) agents.